值得注意的是，东阳光长江药业即将与广东东阳光药业完成一体化合并，成为一家集研产销于一体的综合性制药公司。分析人士表示，未来一体化完成后，公司有望成为千亿市值规模医药龙头企业。Dongyangguang Changjiang Technology (01558) rose more than 5% in early trading, up 4.53% to HKD 9.7 as of press time, with a turnover of HKD 9.037 million.
According to the WiseNews App, Dongyangguang Changjiang Technology (01558) rose more than 5% in early trading, up 4.53% to HKD 9.7 as of press time, with a turnover of HKD 9.037 million.
In terms of news, Citic Securities stated that the Hang Seng Composite Index will usher in a new round of review results on August 16, and this adjustment will take effect on September 9. The Hong Kong stock connect will also be adjusted accordingly. The bank expects that 19 symbols will enter the Hong Kong stock connect, including HEC CJ Pharm. Analysts said that after entering the Hong Kong stock connect, the company is expected to seize southbound capital with its stable basic performance and relatively low valuation, and may experience a new round of valuation leap.
It is worth noting that Dongyangguang Changjiang Pharmaceutical is about to complete the integration with Guangdong Dongyangguang Pharmaceutical, becoming a comprehensive pharmaceutical company integrating research, production and sales. Analysts believe that after the integration is completed in the future, the company is expected to become a billion-dollar market cap leading pharmaceutical company.